Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Crispr Therapeutics Ag (NASDAQ: CRSP)

$20.09 USD -$0.33 (-1.62%)
Last Price $20.09
Net Change $-0.33 (-1.62%)
Bid $19.87
Ask Price $20.12
Open Price $21
Previous Close Price $20.42
High Price $21
Low Price $19.38
Number of Trades 227
Volume 48,582
Fifty Two Week High $25 (2017-01-04)
Fifty Two Week Low $11.63 (2017-02-15)
Average Daily Volume 85,559
Share Outstanding 39,810 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $49.3
Recent Earnings $
Annual EPS $-3.17
Last Quarter EPS $
Market Capitalization $0.80B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 39,810
Inst. Shareholder % 24.33%
Annual Net Income $0B
TTM Net Profit Margin $100.01
1-Year Return 44.93%
3-Year Return 44.93%
5-Year Return 44.93%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 49.299999%
Dividends per Share $
Stock Split Ratio
Beta
CRISPR Therapeutics AG is a gene-editing company. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics AG is headquartered in Basel Switzerland.